Have you been newly diagnosed with or suspected of having either acute myelogenous leukemia or high risk myeloid neoplasm? Are you looking for other treatment options? In this study, depending on the specific type of leukemia you have, our study team will determine the different treatment options that we can provide to you.

This is a Phase 2 clinical trial to test the response of the drug combination of ZEN003694 and Talazoparib. In this study, we want to learn whether this combination works to slow the growth of cancer.

Do you have head and neck cancer or soft tissue sarcoma? Are you planning to have surgery to remove your tumor? You may be able to participate in a research study to determine which therapies may be best for future patients. Compensation provided.

The purpose of this study is to better understand how young adults (ages 18 - 39) who have had cancer use entertainment media during and after cancer treatment.

This is a research study to find out which type of sedentary behavior, or sitting, is most strongly associated with cardiovascular disease (CVD) risk in endometrial cancer survivors. Additionally, we hope to better understand your perception of sedentary behavior and sedentary behavior reduction. The findings from this research study will be used to design a future sedentary behavior reduction intervention for endometrial cancer survivors. Participation in this study includes one assessment visit (during your regularly scheduled clinic visits) where we will measure your blood pressure and arterial stiffness using a blood-pressure like non-invasive device. Additionally, during this visit, you will answer questionnaires, complete a short physical function test (i.e., balance, walking, standing), and be instructed in how to use an accelerometer (movement tracking device worn on your upper thigh) paired with a smart-phone application that will ask you questions about your physical activities and sedentary behavior for 7-days following your

Do you have glioblastoma? Has your cancer either come back or did not improve after the treatments you received? If so, you may be eligible to participate in this gene therapy research study that wants to learn if a new way to modify your immune cells for use as possible treatment is safe and at what dose.

Have you been diagnosed with Leukemia and are looking for another treatment option? In this study we are looking to see if the study drug DSP-5336 can help control Leukemia or achieve remission.

Have you been diagnosed with advanced unresectable pancreatic cancer. If so, you may be able to take part in a research study looking at the safety and tolerability of olaparib in combination with durvalumab and radiation therapy in patients with pancreatic cancer.

To evaluate the effectiveness of using a combination of pembrolizumab and olaparib when given before and after standard chemoradiation therapy in treating locally advanced head and neck squamous cell carcinoma

Do you have a newly diagnosed endometrial cancer? if so, you may be eligible to participate in a research study looking at the role the uterine and gut microbiomes play in endometrial cancer development and treatment.